CPAP for Motion Management in Breast Radiotherapy; and Lung & Liver SABR

ConditionCancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWaikato Hospital

About this trial

A phase II trial to determine the proportion of patients where the use of continuous positive airway pressure (CPAP) results in a superior radiation plan compared to standard planning procedures. The rationale for using CPAP with radiotherapy is based on its ability to increase the tidal volume, flatten the diaphragm thus reducing respiratory excursions.The resultant lung hyperinflation and reduced respiratory excursions can be harnessed for radiotherapy purposes by:

1. Displacing the heart away from the radiotherapy field 2. Reducing the volume of functional lung irradiated 3. Reducing the radiotherapy target motion

CPAP has been shown to be superior to free breathing radiotherapy (RT), however it remains unclear how much benefit it confers vs other motion management adjuncts such as deep inspiration breath hold (DIBH) or 4-DCT.

Eligibility criteria

Qualifiers

Any patient with pathologically-confirmed invasive breast cancer and planned for adjuvant radiotherapy to the breast or chest-wall with regional lymph node coverage

Any patient deemed suitable for lung or liver SABR as per departmental guidelines

Must have signed written informed consent

Disqualifiers

Cannot tolerate CPAP e.g due to severe claustrophobia

Re-irradiation

Trial design

Treatments tested in this trial

  • CPAP

Treatment groups

70 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators